Fangye Zhou | Pathogenic Microorganism | Best Researcher Award

Dr. Fangye Zhou | Pathogenic Microorganism | Best Researcher Award 

Dr. Fangye Zhou is a medical researcher at Chengdu Fifth People’s Hospital, Chengdu University of Traditional Chinese Medicine. Her work focuses on infectious diseases, pediatric health, and molecular diagnostics. As the first author of numerous peer-reviewed studies, she has made significant contributions in virology, immunology, and proteomics. Her expertise spans vaccine development, biomarker discovery, and clinical diagnostics, making her a key figure in translational medical research.

Dr. Fangye Zhou | Chengdu Fifth People’s Hospital, Chengdu University of T.C.M | China

Profile

SCOPUS

Education

  • Fangye Zhou has built a strong foundation in the medical sciences, with a focus on microbiology, immunology, and clinical diagnostics. Her academic background has equipped her with the knowledge necessary to lead investigations across various infectious and systemic diseases. Her education has supported her contributions to both laboratory-based and clinical research, particularly within the context of virology, pediatrics, and chronic diseases.

Experience

  • Fangye Zhou is affiliated with Chengdu Fifth People’s Hospital at Chengdu University of Traditional Chinese Medicine. Her clinical and research work centers around infectious diseases, pediatric health, immunology, and diagnostic medicine. She has independently led multiple studies as the first author, contributing valuable findings to the global understanding of diseases such as influenza, HBV, hand-foot-mouth disease, and neonatal infections. Her clinical setting provides a dynamic environment for integrating research with patient care.

Awards and Recognition

  • Fangye Zhou’s consistent role as the first author in peer-reviewed international journals underscores her leadership and innovation in medical research. Her studies have been published in prominent journals across various disciplines, reflecting recognition by the scientific community for her high-impact research. Her multidisciplinary approach and publications in fields such as clinical biochemistry, virology, and pharmacological sciences indicate a researcher of notable achievement.

Skills and Expertise

  • Zhou demonstrates expertise in molecular diagnostics, immunological assays, quantitative proteomics, and clinical data analysis. She is skilled in laboratory techniques such as iTRAQ-based proteomic analysis, cytokine profiling, and virological reconstruction. Her clinical insight complements her scientific rigor, allowing her to translate laboratory discoveries into relevant applications in patient diagnosis and management.

Research Focus 

  • Her research primarily focuses on virology, neonatal health, proteomics, and molecular diagnostics. She has explored the effectiveness of vaccine candidates, immune responses in chronic infections, and biomarker identification for disease severity and diagnosis. A significant portion of her work also investigates the genetic and proteomic aspects of common and emerging diseases, contributing to more precise and early diagnostics in clinical settings.

Publications

  • Diagnostic Value of Serum Adenosine Deaminase in Myelodysplastic Syndromes: an Observational Study
    Authors: Fangye Zhou
    Journal: Clinical Laboratory (Clin. Lab.)

  • Vero cell based highly pathogenic avian influenza virus H5N1 vaccine candidate with stable high yield
    Authors: Fangye Zhou
    Journal: Biochemical and Biophysical Research Communications (BBRC)

  • Burkholderia gladioli infection isolated from the blood cultures of the newborns in the neonatal intensive care unit
    Authors: Fangye Zhou
    Journal: European Journal of Clinical Microbiology & Infectious Diseases

  • Reconstructed H3N2 influenza virus which predicted from influenza vaccine strains improve cross-protective immunity in mice
    Authors: Fangye Zhou
    Journal: African Journal of Microbiology Research

  • The Association Study of Genetic Polymorphisms of GALNT3 and VDR with Osteoporosis in Postmenopausal women
    Authors: Fangye Zhou
    Journal: Experimental and Therapeutic Medicine

Conclusion

  • Fangye Zhou is a dedicated medical researcher with a strong clinical foundation and an extensive record of publications that highlight her expertise in infectious disease diagnostics, pediatric health, and molecular biology. Her multidisciplinary focus, analytical skills, and leadership in research make her a valuable contributor to the medical and scientific community. She is poised to continue making impactful contributions to clinical medicine and translational research.

Dr. Fei Liu | Biological Sciences | Pioneering Scientist Distinction Award-1552

Dr. Fei Liu | Biological Sciences | Pioneering Scientist Distinction Award

Fei Liu is an associate professor at the School of Life Sciences, Henan University. He holds a Ph.D. in crop genetics and breeding from Huazhong Agricultural University. His research focuses on plant disease resistance, genetic improvement, and molecular mechanisms in oil crops, particularly Brassica species. He has extensive experience in plant pathology and molecular biology, having worked at the Oil Crops Research Institute, the University of Manitoba, and multiple national research projects. Recognized as a Top Young Talent in Central Plains, he actively contributes as an editor and reviewer for leading scientific journals.

Dr. Fei Liu | School of life sciences, Henan University | China

🎓 Education

  • Fei Liu earned a Ph.D. in crop genetics and breeding from the National Key Laboratory of Crop Genetic Improvement and the National Center of Rapeseed Improvement at Huazhong Agricultural University, completing the program in June 2015. Prior to that, he obtained a Bachelor of Science degree in agronomy from the College of Plant Science and Technology at Huazhong Agricultural University in 2008.

💼 Experience

  • Fei Liu has accumulated extensive experience in both research and academia. From June to December 2015, he worked at the Oil Crops Research Institute of the Chinese Academy of Agricultural Sciences. He then pursued postdoctoral research at the Department of Plant Science, University of Manitoba, from January 2016 to August 2020. Since March 2021, he has been serving as an associate professor at the School of Life Sciences, Henan University.

🔥 Awards and Achievements

  • Fei Liu has received significant research funding and recognition for his contributions to plant science. He is a recipient of the Top Young Talents in Central Plains and has secured multiple research grants, including the Key Scientific Research Projects in Colleges and Universities of Henan Province, the International Science and Technology Cooperation Program in Henan Province, the Natural Science Foundation of Henan Province, and the National Key Research and Development Program of China.

🛠️ Skills and Certifications

  • Fei Liu is skilled in molecular biology, plant pathology, and genetic engineering techniques related to crop improvement. He has actively contributed to the scientific community as an editor and reviewer for journals such as Frontiers in Plant Science, Sustainability, Horticulturae, Plants, and the International Journal of Molecular Sciences. He has also organized a special issue focused on improving yield, quality, and resistance in oil crops. His work has been widely presented at international conferences through oral and poster presentations.

🔬 Research Focus

  • His research primarily revolves around plant disease resistance, genetic improvement, and molecular mechanisms in oil crops, particularly Brassica species. He has contributed to projects on the cloning of defense-related genes, functional analyses of WRKY transcription factors in disease resistance, and pathogen population dynamics for sustainable blackleg resistance in canola. His studies have led to the identification of resistance genes and the characterization of pathogenicity factors in fungal infections affecting rapeseed crops.

Conclusion

  • Dr. Fei Liu is a highly accomplished researcher whose pioneering work in plant genetics, transcription factors, and crop resilience makes him an outstanding candidate for the Research for Pioneering Scientist Distinction Award. His contributions to understanding stress responses in Brassica napus, particularly in disease resistance mechanisms against Sclerotinia sclerotiorum, have significantly advanced agricultural biotechnology.

📄Publications

  • The central role of transcription factors in bridging biotic and abiotic stress responses for plants’ resilience
    Authors: Fei Liu, Mengwei Xi, Tong Liu, Xinyu Wu, Lingyue Ju, Daojie Wang
    Journal: New Crops (2024)

  • Transcription factor WRKY28 curbs WRKY33-mediated resistance to Sclerotinia sclerotiorum in Brassica napus
    Authors: Ka Zhang, Fei Liu, Zhixin Wang, Chenjian Zhuo, Kaining Hu, Xiaoxia Li, Jing Wen, Bin Yi, Jinxiong Shen, Chaozhi Ma et al.
    Journal: Plant Physiology (2022)

  • BnaA03.MKK5-BnaA06.MPK3/BnaC03.MPK3 Module Positively Contributes to Sclerotinia sclerotiorum Resistance in Brassica napus
    Authors: Ka Zhang, Chenjian Zhuo, Zhixin Wang, Fei Liu, Jing Wen, Bin Yi, Jinxiong Shen, Chaozhi Ma, Tingdong Fu, Jinxing Tu
    Journal: Plants (2022)

  • Genome-Wide Identification and Analysis of the Valine-Glutamine Motif-Containing Gene Family in Brassica napus and Functional Characterization of BnMKS1 in Response to Leptosphaeria maculans
    Authors: Zou Z, Liu F, Huang S, Fernando WGD
    Journal: Phytopathology (2021)

  • BnaA03.WRKY28, interacting with BnaA09.VQ12, acts as a brake factor of activated BnWRKY33-mediated resistance outburst against Sclerotinia sclerotiorum in Brassica napus
    Authors: Ka Zhang, Fei Liu, Zhixin Wang, Chenjian Zhuo, Kaining Hu, Xiaoxia Li, Jing Wen, Bin Yi, Jinxiong Shen, Chaozhi Ma et al.
    Journal: Preprint (2021)